AstraZeneca said to have explored Bristol Myers merger
- Posted on August 2, 2026
- By Fortune
- 0 Views
- 1 min read
In brief
Generating AI summary…
AstraZeneca said to have explored Bristol Myers merger
Bristol Myers Squibb, which has a $133 billion market capitalization, could provide AstraZeneca with a bigger foothold in the US market.